KRT6A and Alzheimer disease: They identified that four circulating EV proteins, including alpha-1-antichymotrypsin (AACT) isoform 1, complement component 9, immunoglobulin heavy constant mu Isoform 2, and keratin, type II cytoskeletal 6 A, are significantly up-regulated in AD patients compared with control individuals.